as well as a doctorate degree in research on glioblastoma from the University at Cologne in Germany. We found this to be an interesting nuance given the street-wide perception that GW is only an epilepsy platform. It’s not uncommon for a biotech company to have a promising pipeline; it is uncommon, however, for analysts to assign no value to it. Only eight Wall Street analysts cover the stock and for the most part, all of them base the entirety of their price targets on the blockbuster potential for Epidiolex ™. We don’t think they understand the story, just as most people don’t understand cannabis; and therein lies the opportunity.
The chasm between perception and reality is where profits are found, and most of the world still views ‘pot’ as a gateway drug. By the time clinical validation arrives, and other people understand that cannabis is more impact investing than vice-fund fringe, GW Pharmaceuticals, more than any other stock in the cannabis universe, is poised to benefit the most. (Disclosure: At the time of writing this article, CB1 Capital Management has a position in GW Pharmaceuticals, Tilray and Canopy Growth Corporation) Can Namaste Technologies Become The Amazon Of Cannabis? A ladybug crawls on the leaf of a hemp plant grown for medical research in Thailand. [+] Taylor Weidman/Bloomberg) As the Canadian market prepares for the anticipated rise in the demand for recreational cannabis post its legalization in October, Namaste Technologies, (CVE:N), a leading online retailer of ancillary hardware cannabis products, is busy spreading its roots in the online cannabis market. Just like the large cannabis producers, Namaste’s stock has surged, rising from $0.21 per share in November 2017 to $3.55 per share at present. However, the company hasn’t stopped growing, and aims to become the “Amazon of the cannabis market” in the coming years.
For this, the company announced the pre-launch of an artificial intelligence-driven medical cannabis marketplace – CannMart.com – which would enable it to procure and sell medical cannabis from both domestic and international cultivators. In this note, we discuss how this move will augment Namaste Technologies’ plans to become the “Amazon of the Cannabis Market.” We currently have a price estimate of $7.00 per share for Namaste Technologies , which is higher than its market price. View our interactive dashboard – Namaste Technologies’ Price Estimate – and modify the key drivers to visualize the impact on its valuation. Namaste Technologies is a Vancouver-based online retailer of medical cannabis vaporizers and smoking accessories. The company is one of the largest online retailers of cannabis delivery systems, operating through its 32 e-commerce sites in over 20 countries and distribution hubs located across the globe. The company’s websites have over 600,000 monthly visits with a database of approximately 1.5 million users. The company has a strong presence in the UK, Canada, and Germany and holds a large chunk of the online cannabis markets in Europe and Australia. With the growing demand for medical cannabis products, the company is catering to the emerging markets such as Brazil, Mexico, and Chile through a number of new supply channels. 20-Year-Old Robinhood Customer Dies By Suicide After Seeing A $730,000 Negative Balance. Asked About Possible Second Stimulus Check, Trump Says There Will Be A Second Bipartisan Package. 1 Novak Djokovic—Who Is Opposed To A Coronavirus Vaccine—Tests Positive For Virus After Widely Criticized Exhibition Tournament. In 2017, Namaste Technologies acquired CannMart Inc., a Canada-based late-stage applicant for a medical cannabis sales-only license under Health Canada’s Access to Cannabis for Medical Purposes Regulations. The acquisition was a strategic decision, taken to strengthen Namaste’s e-commerce and logistics platform and enable it to establish a stronger presence in retail distribution of medical cannabis in Canada. In the quest to achieve this objective, Namaste announced the pre-launch of a medical cannabis online marketplace – CannMart.com – earlier this week. The company has launched this marketplace, given its expectations that its subsidiary, CannMart, will receive its sales-only license in the coming months. Once this milestone is achieved, Namaste will be able to procure and sell medical cannabis from both domestic and international Health Canada approved cultivators and offer them on an AI-driven e-commerce marketplace designed to provide a unique and personalized experience to each patient. AI-driven Marketplace And Strong Network Of Suppliers Will Drive Sales. Namaste will incorporate the advance e-commerce AI from its existing technology platform – NamasteMD , Canada’s first fully integrated patient consultation portal, to create a personalized user experience for every patient ordering through CannMart.com. In addition, the company will further integrate the AI technology and expertise of Findify , a leading e-commerce AI company that Namaste had acquired in May 2018, into the new platform. Furthermore, the company plans to leverage the database of over 1.5 million customers to expand its presence in the online cannabis market in Canada and gradually across the globe. Apart from this, Namaste has secured a network of suppliers and holds an inventory of medical cannabis flower and oil, which will be immediately available for sale once CannMart receives its sales-only license. Namaste’s existing platform is known for its safe and reliable distribution and is in line with the current provincial and federal guidelines for the sale of cannabis within Canada. The new marketplace will enable Namaste to become a one-stop-shop for medical cannabis consumers in Canada by offering both cannabis consumables as well as ancillary products on the same platform, assuming approval.
Thus, we expect CannMart’s sales-only license, coupled with an AI-driven marketplace to sell cannabis products, to solidify Namaste’s position as a leader in the cannabis e-commerce market in the coming years. Explore example interactive dashboards and create your own.
Over 50,000 businesses use BirdEye everyday to get more reviews and manage all customer feedback. BirdEye helps millions of local businesses to be found online with all their reviews and accurate business information. Yes- salon's will reopen- at some point- different for every state, every salon. What can CLIENTS do to help salons navigate a new 'normal' you ask?